A carregar...
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial
IMPORTANCE: Migraine is a disabling neurological disease characterized by severe headache attacks. Treatment options reduce migraine frequency for many patients, but adverse effects lead to discontinuation in many patients. OBJECTIVE: To demonstrate that galcanezumab is superior to placebo in the pr...
Na minha lista:
| Publicado no: | JAMA Neurol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6143119/ https://ncbi.nlm.nih.gov/pubmed/29813147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.1212 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|